SCHEMBL1988552

SCHEMBL1988552

O=[N+]([O-])c1ccc(C(O)(CCCO)c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.49
ALDH1A1 P00352 5/20 0.45
POLB P06746 2/20 0.45
HSD11B1 P28845 1/20 0.41
CYP19A1 P11511 1/20 0.41
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CES1 P23141 1/20 0.40
CA5A P35218 1/20 0.40
CA9 Q16790 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP2C19 P33261 1/20 0.39
GSK3B P49841 1/20 0.39
ACHE P22303 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1985446 0.92 MEN1 (0.48) TSHRALDH1A1POLBHSD11B1CYP19A1
SCHEMBL1981967 0.85 VCAM1 (0.41) TSHRALDH1A1POLBGAAMAPT
SCHEMBL1981965 0.81 PTPRC (0.51) TSHRALDH1A1POLBCES1MAPT
SCHEMBL335896 0.76 TSHR (0.49) TSHRALDH1A1POLBHSD11B1CYP19A1
SCHEMBL4404511 0.76 TSHR (0.49) TSHRALDH1A1POLBHSD11B1CYP19A1
SCHEMBL13401464 0.76 ALDH1A1 (0.49) TSHRALDH1A1POLBHSD11B1CYP19A1
SCHEMBL14958565 0.76 ALDH1A1 (0.47) TSHRALDH1A1POLBHSD11B1CYP19A1
SCHEMBL9733853 0.76 CES1 (0.49) TSHRALDH1A1POLBCA1CA2
SCHEMBL1987767 0.75 VCAM1 (0.46) ALDH1A1POLBMAPT
Ethylene Glycol SCHEMBL28236042 0.74 TSHR (0.71) TSHRALDH1A1POLBCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2337781-A2 ANTI-VIRAL COMPOUNDS TO TREAT HCV INFECTION Abbott Laboratories (US) 2011-06-29 EP disclosed
WO-2010144646-A2 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2010-12-16 WO disclosed